Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There are 2 pending office actions currently active for this entity. These actions represent the current legal hurdles the company faces in the biotech and pharma sectors. The presence of 2 pending office actions indicates a focused but active prosecution pipeline.
The 2 pending office actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution shows that the company's technology is being reviewed by 2 different specialized divisions within the patent office. Because there are 2 distinct examiners involved, the company must manage 2 separate lines of communication. The use of 2 distinct art units further indicates that the pending applications cover different technical classifications within the broader biotechnology field.
RYAN, DOUGLAS CHARLES is identified as the busiest examiner, with 1 pending office action. Since the total number of pending actions is 2 and there are 2 distinct examiners, each examiner is handling 1 action. This balanced workload between the 2 distinct examiners means the company must satisfy 2 different officials. The practitioner must address the individual requirements of each examiner while navigating the technical standards of the 2 distinct art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RYAN, DOUGLAS CHARLES | 1 | 38.2% | +48.4% |
| TAYLOR, LIA ELAN | 1 | 64.2% | +29.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17636425 | Anti-C7 Antibody Or Antibody Fragment | TAYLOR, LIA ELAN | 19d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042193 | A METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS | RYAN, DOUGLAS CHARLES | 3d overdue |
| 17636425 | Anti-C7 Antibody Or Antibody Fragment | TAYLOR, LIA ELAN | 19d |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18042193 | A METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS | RYAN, DOUGLAS CHARLES | 1635 | §103§112DP | Final Rejection | 3d overdue | Pending | Feb 17, 2023 |
| 17636425 | Anti-C7 Antibody Or Antibody Fragment | TAYLOR, LIA ELAN | 1641 | §101§112 | Final Rejection | 19d | Pending | Feb 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Douglas Charles Ryan has the most, with 1 of UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
